Literature DB >> 18617987

Some Geometric Methods for Constructing Decision Criteria Based On Two-Dimensional Parameters.

Peter F Thall1.   

Abstract

This paper reviews two types of geometric methods proposed in recent years for defining statistical decision rules based on 2-dimensional parameters that characterize treatment effect in a medical setting. A common example is that of making decisions, such as comparing treatments or selecting a best dose, based on both the probability of efficacy and the probability toxicity. In most applications, the 2-dimensional parameter is defined in terms of a model parameter of higher dimension including effects of treatment and possibly covariates. Each method uses a geometric construct in the 2-dimensional parameter space based on a set of elicited parameter pairs as a basis for defining decision rules. The first construct is a family of contours that partitions the parameter space, with the contours constructed so that all parameter pairs on a given contour are equally desirable. The partition is used to define statistical decision rules that discriminate between parameter pairs in term of their desirabilities. The second construct is a convex 2-dimensional set of desirable parameter pairs, with decisions based on posterior probabilities of this set for given combinations of treatments and covariates under a Bayesian formulation. A general framework for all of these methods is provided, and each method is illustrated by one or more applications.

Entities:  

Year:  2008        PMID: 18617987      PMCID: PMC2906756          DOI: 10.1016/j.jspi.2007.06.013

Source DB:  PubMed          Journal:  J Stat Plan Inference        ISSN: 0378-3758            Impact factor:   1.111


  11 in total

1.  Approximate Bayesian evaluation of multiple treatment effects.

Authors:  P F Thall; R M Simon; Y Shen
Journal:  Biometrics       Date:  2000-03       Impact factor: 2.571

2.  Treatment comparisons based on two-dimensional safety and efficacy alternatives in oncology trials.

Authors:  P F Thall; S C Cheng
Journal:  Biometrics       Date:  1999-09       Impact factor: 2.571

3.  Dynamic treatment regimes: practical design considerations.

Authors:  Philip W Lavori; Ree Dawson
Journal:  Clin Trials       Date:  2004-02       Impact factor: 2.486

4.  Adaptive dose selection using efficacy-toxicity trade-offs: illustrations and practical considerations.

Authors:  Peter F Thall; John D Cook; Elihu H Estey
Journal:  J Biopharm Stat       Date:  2006       Impact factor: 1.051

5.  Group sequential tests for bivariate response: interim analyses of clinical trials with both efficacy and safety endpoints.

Authors:  C Jennison; B W Turnbull
Journal:  Biometrics       Date:  1993-09       Impact factor: 2.571

6.  Incorporating toxicity considerations into the design of two-stage phase II clinical trials.

Authors:  J Bryant; R Day
Journal:  Biometrics       Date:  1995-12       Impact factor: 2.571

7.  Bivariate sequential designs for phase II trials.

Authors:  M R Conaway; G R Petroni
Journal:  Biometrics       Date:  1995-06       Impact factor: 2.571

8.  Dose-finding based on efficacy-toxicity trade-offs.

Authors:  Peter F Thall; John D Cook
Journal:  Biometrics       Date:  2004-09       Impact factor: 2.571

9.  Parametric approaches to quality-adjusted survival analysis. International Breast Cancer Study Group.

Authors:  B F Cole; R D Gelber; K M Anderson
Journal:  Biometrics       Date:  1994-09       Impact factor: 2.571

10.  A quality-of-life-oriented endpoint for comparing therapies.

Authors:  R D Gelber; R S Gelman; A Goldhirsch
Journal:  Biometrics       Date:  1989-09       Impact factor: 2.571

View more
  1 in total

1.  Linear Fitted-Q Iteration with Multiple Reward Functions.

Authors:  Daniel J Lizotte; Michael Bowling; Susan A Murphy
Journal:  J Mach Learn Res       Date:  2012-11       Impact factor: 3.654

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.